CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q/A Report 10-Q/A
- 10-Q/A Report 10-Q/A
- 10-Q/A Report 10-Q/A
- 10-K/A Report 10-K/A
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy President - Asia Pacific bought 2,500 shares at $1.92 ($4,800)
- 4 Open-market buy Director bought 17,500 shares at an average $1.96 ($34,225)
- 4 Open-market buy Director bought 13,449 shares at an average $2.06 ($27,720)
- 4 Open-market buy Director bought 5,000 shares at an average $2.66 ($13,285)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- REGDEX Other REGDEX
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Open-market buy Director bought 4,000 shares at $3.81 ($15,240)
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-3 Offering Registration Statement
- SC 13D/A Stake Beneficial Ownership Report
Page 57 of 74 · 1,465 filings